Dr.Zone AI

Jubran Alnajar | Internal Medicine | Dr.Zone AI

Jubran Alnajar (Internal Medicine): At the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting held in Chicago, one of the most notable presentations was the Phase III RASolute 302 clinical trial, which generated...